Clinical Trial Update: Safety and Efficacy of Entospletinib With Vincristine and Dexamethasone in Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating entospletinib with vincristine and dexamethasone in adults with relapsed or refractory acute lymphoblastic leukemia; trial terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Entospletinib (entospletinib)
• Vincristine (vincristine)

Snippet

Sponsor: Gilead Sciences | Conditions: Acute Lymphoblastic Leukemia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2019-12-02